Wealth Enhancement Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$109M Sell
340,323
-123,897
-27% -$49.4M 0.16% 112
2026
Q2
$142M Buy
464,220
+75,502
+19% +$25.8M 0.24% 70
2026
Q1
$110M Buy
388,718
+10,497
+3% +$3.74M 0.23% 83
2025
Q4
$126M Sell
378,221
-22,365
-6% -$7.09M 0.17% 104
2025
Q3
$118M Buy
400,586
+1,401
+0.4% +$406K 0.18% 113
2025
Q2
$119M Buy
399,185
+14,017
+4% +$3.97M 0.2% 98
2025
Q1
$120M Sell
385,168
-133,628
-26% -$39.5M 0.23% 82
2024
Q4
$135M Buy
518,796
+192,820
+59% +$57.2M 0.26% 72
2024
Q3
$105M Sell
325,976
-15,702
-5% -$5.14M 0.23% 87
2024
Q2
$107M Buy
341,678
+14,812
+5% +$4.35M 0.25% 80
2024
Q1
$92.9M Buy
326,866
+19,029
+6% +$5.57M 0.24% 89
2023
Q4
$88.7M Buy
307,837
+10,146
+3% +$2.76M 0.26% 86
2023
Q3
$80M Buy
297,691
+296,057
+18,119% +$73.9M 0.26% 83
2023
Q2
$363K Sell
1,634
-24,079
-94% -$5.59M ﹤0.01% 397
2023
Q1
$6.22M Buy
25,713
+24,888
+3,017% +$6.11M 0.07% 119
2022
Q4
$208K Buy
+825
New +$221K ﹤0.01% 314
2022
Q3
– Sell
-54,205
Closed -$13.5M – 321
2022
Q2
$13.5M Buy
54,205
+53,352
+6,255% +$13.1M 0.19% 70
2022
Q1
$209K Buy
+853
New +$196K ﹤0.01% 309
2021
Q2
– Sell
-17,023
Closed -$4.24M – 267
2021
Q1
$4.24M Buy
17,023
+511
+3% +$122K 0.08% 108
2020
Q4
$4.05M Buy
+16,512
New +$3.81M 0.09% 86
2020
Q1
– Sell
-19,937
Closed -$4.81M – 216
2019
Q4
$4.81M Buy
19,937
+5,009
+34% +$1.1M 0.17% 64
2019
Q3
$3M Buy
+14,928
New +$2.87M 0.12% 78
2019
Q2
– Sell
-7,893
Closed -$1.42M – 202
2019
Q1
$1.42M Sell
7,893
-7,915
-50% -$1.51M 0.08% 102
2018
Q4
$3.22M Sell
15,808
-1,951
-11% -$381K 0.2% 45
2018
Q3
$3.34M Buy
+17,759
New +$3.5M 0.2% 39
2017
Q4
– Sell
-5,177
Closed -$962K – 140
2017
Q3
$962K Sell
5,177
-4,413
-46% -$782K 0.08% 100
2017
Q2
$1.67M Buy
+9,590
New +$1.56M 0.15% 69
2016
Q4
– Sell
-8,821
Closed -$1.48M – 141
2016
Q3
$1.48M Buy
+8,821
New +$1.49M 0.22% 66

Other funds holding AMGN

Wealth Enhancement Advisory Services's AMGN Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Amgen (AMGN) stake by 27% in Q3 2026, selling an estimated $49.4M and leaving 340,323 shares worth $109M. The position accounts for 0.16% of the portfolio, ranked #112.

Wealth Enhancement Advisory Services first reported a position in AMGN in Q3 2016 and has held it in 28 quarters since. The position peaked at $142M in Q2 2026. 3,274 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Wealth Enhancement Advisory Services held 340,323 shares of Amgen worth $109M as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 123,897 Amgen shares in Q3 2026, an estimated $49.4M.
  • Amgen made up 0.16% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #112 holding.
  • Wealth Enhancement Advisory Services first reported a position in Amgen in Q3 2016 and has held it in 28 quarters since.
  • Wealth Enhancement Advisory Services's Amgen position peaked at $142M in Q2 2026.
  • 3,274 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.